• SENSEX 76,386.20
    -368.85 (--0.48%)
  • BANKNIFTY 57,126.80
    -708.55 (--1.23%)
  • Millworks Technologies
    727.95 693.30(%)
  • Gandhar Oil Ref.
    277.00 245.00(%)
  • SBI Funds Mgt.
    580.05 582.55(%)
  • Lords Mark Industries
    95.00 669.70(%)
  • Oracle Fin.Serv.
    11,330.95 11,986.90(%)
  • Cropster Agro
    7.26 4.86(%)
  • Devson Catalyst
    219.00 227.00(%)
  • Bluestone Jewel
    774.95 400.40(%)
  • H P C L
    385.00 316.20(%)
  • Indo SMC
    427.25 442.00(%)
  • Jio Financial
    232.20 223.30(%)
  • Data Pattern
    4,679.95 2,131.00(%)
  • IIFL Finance
    586.70 674.95(%)
  • Kalyan Jewellers
    599.00 617.30(%)
  • 360 ONE
    1,064.70 906.20(%)
  • HDFC Bank
    750.00 726.75(%)
  • Omega Interactiv
    50.08 112.06(%)
  • Adani Power
    217.65 254.15(%)
  • Eternal
    290.80 368.40(%)
  • MTAR Technologie
    5,960.00 8,714.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Cohance Lifesciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 74679.0
  • ISIN : INE03QK01018
438.10 -8 (-1.69%)
  • As on 23 Jul 2026 (EOD)

  • Today’s Low

    433.10

  • Today’s High

    445.40

  • Open

    445.00

  • Perv Close

    445.65

  • 52W Low

    266.70

  • 52W High

    1,079.00

Key Indicators

  • P/E(TTM)

    67.12

  • Mar.Cap (₹Cr.)

    16,760.27

  • Div & Yield %

    0.00

  • Book Value(₹)

    117.11

  • Debt-Equity Ratio

    -1.69

  • AGM Date

    22-Jul-2026

  • EPS

    6.54

  • P/E Ratio

    67.12

Financials Ratios

  • Debt-Equity Ratio

    0.04

  • Mar.Cap (₹Cr.)

    16,760.27

  • RONW (%)

    14.11

  • ROCE (%)

    18.69

Score Board

  • Equity (₹ in Cr.)

    38.26

  • BV (₹)

    117.10

  • Sales( ₹ in Cr.)

    2,030.50

  • NP (in Cr.)

    250.20

  • NP Var(%)

    -8.0

  • Div%

    0.0

  • CPS (₹)

    10.00

  • EPS (₹)

    6.50

  • Traded Value (₹ in Lakhs)

    16,792.78

  • 52 Week High

    1,079.00

  • 52 Week Low

    266.70

  • Price BSE

    439.0

  • Price NSE

    438.00

  • Market Capital( in Cr.)

    16,792.78

  • P/C Ratio

    43.80

  • P/E Ratio

    67.10

  • Price Vs.BV

    6.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,093.51 1,051.35 1,330.08 1,320.22 1,009.72 833.79
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,093.51 1,051.35 1,330.08 1,320.22 1,009.72 833.79
Other Income 53.98 56.61 44.55 187.79 14.24 18.12
Stock Adjustments -86.53 -49.16 20.94 60.35 8.37 11.05
Total Income 1,060.96 1,058.80 1,395.57 1,568.36 1,032.33 862.96
EXPENDITURE :            
Raw Materials 212.51 265.88 421.36 459.46 310.32 240.24
Power and Fuel Cost 42.19 48.30 71.35 59.55 44.20 38.24
Employee Cost 198.30 135.23 108.58 100.48 76.23 65.10
Other Manufacturing Expenses 111.71 88.31 101.96 115.25 90.76 66.49
Selling and Administration Expenses 47.84 37.51 43.57 52.38 44.93 44.72
Miscellaneous Expenses 31.86 21.10 13.50 11.17 8.61 5.26
Employee Benefit Expenses 198.30 135.23 108.58 100.48 76.23 65.10
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 644.41 596.33 760.33 798.29 575.05 460.05
Operating Profit 416.55 462.47 635.24 770.08 457.28 402.91
Interest 8.00 7.45 12.75 8.53 11.66 21.81
Gross Profit 408.55 455.02 622.49 761.55 445.62 381.10
Depreciation 57.20 54.60 43.10 39.10 31.64 23.51
Profit Before Tax 351.35 400.42 579.39 722.45 413.98 357.59
Current Tax 92.37 97.36 142.45 157.63 101.72 88.81
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -12.73 6.59 4.34 6.72 3.62 -1.30
Reported Net Profit 271.71 296.47 432.60 558.10 308.65 270.08
Extraordinary Items -0.06 -0.05 10.55 14.53 2.51 4.73
Adjusted Net Profit 271.77 296.52 422.05 543.57 306.14 265.35
Adjustment below Net Profit 0.57 -0.32 -0.26 -0.76 -0.84 -13.90
P & L Balance brought forward 1,767.06 1,470.91 1,276.39 835.88 568.52 390.98
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 218.65 116.83 40.46 78.64
P & L Balance carried down 2,039.34 1,767.06 1,490.07 1,276.39 835.88 568.52
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 600.00 500.00 200.00 500.00
Dividend Per Share(Rs) 0.00 0.00 6.00 5.00 2.00 5.00
Earnings Per Share-Unit Curr 10.67 11.64 16.99 21.92 12.12 21.22
Earnings Per Share(Adj)-Unit Curr 10.67 11.64 16.99 21.92 12.12 10.61
Book Value 90.95 79.67 68.72 59.74 41.84 61.50
Book Value(Adj)-Unit Curr 90.95 79.67 68.72 59.74 41.84 30.75

Shareholding Pattern

  • Promoter Group

    57.49%

  • Public Share Holding

    42.51%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 219,930,170 57.49 219,930,170 2
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 219,930,170 57.49 219,930,170 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 40,034 0.01 40,034 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 211 0.00 211 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 24,856,830 6.50 24,856,830 107
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6,761,779 1.77 6,761,779 2
Mutual Funds / UTI 69,647,356 18.21 69,611,356 25
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 439,663 0.11 439,663 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 101,745,873 26.60 101,709,873 146
2] Non Institution
Bodies Corporate 27,990,100 7.32 27,986,100 595
Clearing Members 47 0.00 47 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,148,685 0.56 2,148,685 2,608
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 877,928 0.23 877,428 1,508
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,230,855 0.32 1,228,855 4
Individuals holding nominal share capital up to Rs. 1 lakh 28,257,507 7.39 27,939,156 94,275
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,631 0.00 2,631 7
Others 348,438 0.09 348,438 1
Sub Total 60,891,097 15.92 60,566,246 99,001
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 382,567,140 100.00 382,206,289 99,149

Company Background

Cohance Lifesciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Cohance Lifesciences Ltd
  • BSE Code : 74679.0
  • ISIN : INE03QK01018

  • Incorporation Year

    2018

  • Registered Office

    8-2-334 SDE Serene Chambers
    3 Floor Avenue 7 Road No 5, Hyderabad,
    Telangana-500034

  • Telephone

    91-40-23549414/1142/3311

  • FAX

    91-40-23541152

  • Chairman

    Vivek Sharma

  • Managing Director

  • Company Secretary

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Cohance Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Cohance Life 438.95 1,147.49 1,093.51 73.40 15.94
P & G Health Ltd 6,718.20 944.52 934.17 34.11 71.75
Sanofi India 3,403.50 1,857.10 1,837.40 25.30 54.17
Glaxosmi. Pharma 2,551.10 3,932.76 3,790.20 42.71 58.17
J B Chemicals & 2,412.25 3,945.17 3,889.89 57.46 24.24
Novartis India 1,699.05 398.23 356.27 45.02 16.64
Cipla 1,415.10 20,102.60 18,979.95 32.52 13.88
Amrutanjan Healt 529.35 469.50 451.82 26.43 21.89
Bliss GVS Pharma 448.15 773.53 729.81 49.09 12.51
Guj. Themis Bio. 351.75 152.47 150.80 82.18 27.21
Ambalal Sarabhai 31.49 19.52 3.94 22.02 6.77